@article { ISI:000281964300014, title = {OGA inhibition by GlcNAc-selenazoline}, journal = {BIOORGANIC \& MEDICINAL CHEMISTRY}, volume = {18}, number = {19}, year = {2010}, month = {OCT 1}, pages = {7058-7064}, abstract = {The title compound, which differs from the powerful O-GlcNAcase (OGA) inhibitor GlcNAc-thiazoline only at the chalcogen atom (Se for S), is a much weaker inhibitor in a direct OGA assay. In human cells, however, the selenazoline shows comparable ability to induce hyper-O-GlcNAc-ylation, and the two show similar reduction of insulin-stimulated translocation of glucose transporter 4 in differentiated 3T3 adipocytes. (C) 2010 Elsevier Ltd. All rights reserved.}, issn = {0968-0896}, doi = {10.1016/j.bmc.2010.08.010}, author = {Kim, Eun Ju and Love, Dona C. and Darout, Etzer and Abdo, Mohannad and Rempel, Brian and Withers, Stephen G. and Rablen, Paul R. and Hanover, John A. and Knapp, Spencer} }